I like to invest in disruptive trends; whether in healthcare, tech, finance, ...
I am not a financial advisor, any opinions about stocks are my own views
$SRPT story is worth a PhD dissertation. It has to be written by DI; Title: "How I royally effed a promising company because I was too cocky". @yachmod
@GeneInvesting@crisprspace It's not that big pharma don't see value, it's the fair value compared to current trading price. Definitely, $NTLA is way more valuable than $VERV but today market says $VER is $1.3bn and $NTLA is <=$1.0 bn.